Delivery Order SPE2DB20D3101-SPE2DB23FRJC3
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $32,913.64 firm-fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to support military and government healthcare programs. The contract has an ultimate completion date of December 7, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The $4,389.43 firm fixed price contract is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of July 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,670.30 firm fixed-price delivery order is for the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen, 3 mL), with a completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,354.05 delivery order is for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, with a completion date of August 15, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award, #SPE2DB20D2001|SPE2DB23FM69J, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,458.48 firm-fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The contract has an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,674.09 firm-fixed-price delivery order is for the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has an ultimate completion date of November 20, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $53,727.38 for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical products. The contract has a Firm Fixed Price pricing type and an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $8,338.01 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 21, 2024 with a completion date of February 22, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $8,212.23 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Delivery Order contract, valued at $3,870.01, is for the procurement of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has an ultimate completion date of December 7, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRJC3Delivery Order
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRJC3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,992.42 delivery order is for the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 4/17/23 |